58 reports

  • MARKET SIZE AND FORECAST

Genetic and co-morbid influences also play major roles in the increasing incidences of PVDs.

  • Cardiovascular Devices
  • Interventional Cardiology Device
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic, Inc.

BRUGADA SYNDROME IS A GENETIC DISEASE THAT PREDISPOSES TO HEART ATTACK OR SUDDEN DEATH DUE TO MALIGNANT VENTRICULAR TACHYARRHYTHMIA.

  • Cardiovascular Devices
  • Southern Europe
  • Spain
  • Market Size
  • Boston Scientific Corporation

You can easily book an appointment with one online.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Jude Medical, Inc.
  • Opsens Inc.
  • Interventional Cardiology Device Market: Revenue in USD billion, China, 2015-2023
  • Interventional Cardiology Device Market: Revenue in USD billion, Japan, 2015-2023

The rising prevalence of congenital heart defects, owing to life style factors, miscarriage, and genetic defects, are boosting the demand for interventional cardiology devices.

  • Cardiovascular Devices
  • Abbott
  • B. Braun Melsungen AG
  • C.R. Bard, Inc.
  • Cook Medical, Inc.

A cerebral aneurysm occurs due to hypertension, smoking, injury or trauma to blood vessels, and genetic predisposition.

  • Cardiovascular Devices
  • Abbott Laboratories, Inc.
  • Medtronic, Inc.
  • Stryker Corporation
  • Terumo Corporation

GENETIC MAKEUP ALSO PLAYS A MAJOR PART IN THE DEVELOPMENT OF AORTIC ANEURYSMS.

  • Cardiovascular Devices
  • World
  • Market Size
  • Endologix, Inc.
  • Medtronic, Inc.

ONE UNIT REFERS TO ONE PAL SYSTEM.

  • Cardiovascular Devices
  • East Asia
  • Japan
  • Forecast
  • Olympus Corporation

At least ##% of all CHDs are associated with genetic conditions.

  • Cardiovascular Devices
  • World
  • Market Size
  • Terumo Corporation
  • Toshiba Corporation

The increase in the prevalence of diabetes is common in all age groups of people; genetic factors and changes in lifestyle are some of the reasons for the increase.

  • Cardiovascular Devices
  • United States
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Medtronic, Inc.

Global Peripheral Vascular Devices Market TABLE OF CONTENTS ##.

  • Cardiovascular Devices
  • Boston Scientific Corporation
  • C.R.Bard, Inc.
  • Cordis Corporation
  • Medtronic, Inc.

Vascular; ##(##): ##-##.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Cardinal Health, Inc.

Moreover, a rise in the incidence of genetic comorbidities is one of the factors responsible for the increase in the incidence of diseases that require thoracic surgery.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Sorin S.p.A.
  • Global Percutaneous Coronary Interventions Procedures Forecast ($m), 2013-2022

India is the most significantly impacted by the disease, where genetic factors, in combination with poor diet, have contributed to the rising rate of the disease.

  • Cardiovascular Devices
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Biotronik AG
  • Boston Scientific Corporation
  • 4.4.4 STENT GRAFTS

PERIPHERAL ANEURYSMS ARE USUALLY GENETIC.

  • Cardiovascular Devices
  • World
  • Market Size
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • 06.2 Market Size and Forecast
  • 11. Market Growth Drivers

Genetic and co-morbid factors are major contributors too.

  • Cardiovascular Devices
  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Cordis Corporation
  • Medtronic, Inc.
  • 6.1 Growth Drivers

Increasing consumption of fast food, diet colas, and genetic disorder cases, have aggravated the scale of obese people globally.

  • Cardiovascular Devices
  • World
  • Boston Scientific Corporation
  • Cordis Corporation
  • Johnson & Johnson
  • Market landscape

You can easily book an appointment with one online.

  • Cardiovascular Devices
  • United States
  • Boston Scientific Corporation
  • Medtronic, Inc.
  • Spectranetics Corp.
  • 3.3.2 RESTRAINTS AND THREATS
  • 5.2.2 PERIPHERAL STENTS

KG Woermannkehre ##, ## Berlin, Germany.

  • Cardiovascular Devices
  • World
  • Market Size
  • Abbott
  • Biosensors International Group, Ltd.
  • 4.2.2 Prostatic Stents Market, US$ Mn (2013 - 2019)

Major drivers include increasing adoption of prostatic stents worldwide, genetic susceptibility of certain ethnicity for prostate cancer and BPH (particularly African decent).

  • Cardiovascular Devices
  • World
  • Forecast
  • Boston Scientific Corporation
  • Taewoong Medical

Drivers and Their Impact Impact on Key Customer Category Public Growth in Incidence of Cardiovascular Diseases Increased Awareness Advances in Surgical Procedures Low ## ## ## ## ## High Low ## ## ## ## ## High Low High Low High ## ## ## ## ## ## ## ## ## ## Low High High Low

  • Cardiac Management
  • Cardiovascular Devices
  • Europe
  • Boston Scientific Corporation
  • Jude Medical, Inc.

Drivers and their Impact Impact on key customer category Growing population Advances in EVAR/ TEVAR technology Emergence of regional vendors Improvement healthcare infrastructure elderly Low ## ## ## ## ## High Low High ## ## ## ## ## Low High ## ## ## ## ## High in Low ## ##

  • Cardiovascular Devices
  • China
  • Cook Medical, Inc.
  • Medtronic, Inc.
  • MicroPort Scientific Corporation
  • GLOBAL GERIATRIC POPULATION (60 YEARS AND ABOVE), 2015 VS. 2030

WITH AGE, GENETIC AND LIFESTYLE FACTORS LEAD TO A BUILDUP OF PLAQUE IN THE ARTERIES. ##. ##. ##. ## ACCORDING TO AN ARTICLE PUBLISHED IN THE LANCET JOURNAL IN OCTOBER 2016, THE GLOBAL PREVALENCE OF PERIPHERAL VASCULAR DISEASES WAS ##. ## MILLION IN 2005, WHICH ROSE TO ##. ##

  • Cardiovascular Devices
  • Medical Device
  • North America
  • United States
  • Medtronic, Inc.

Cardiac Resynchronization Therapy Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025 ##.

  • Cardiac Management
  • Cardiovascular Devices
  • Patient Monitoring
  • World
  • Company Financials

One unit refers to one S-ICD.

  • Cardiac Management
  • Cardiovascular Devices
  • Patient Monitoring
  • United States
  • Boston Scientific Corporation
  • CLARET MEDICAL RAISES USD14.5 MILLION IN SERIES C FINANCING

Social risk groups did not differ on presence of genetic syndrome or single ventricle physiology.

  • Cardiovascular Devices
  • Healthcare
  • North America
  • United States
  • Market Size

" IN MANY CASES, CHILDREN BORN WITH A GENETIC CONDITION HAVE NO REPORTED FAMILY HISTORY OF THE DISEASE, " SAID CHRIS GROTTENTHALER, CEO OF TRUE HEALTH.

  • Cardiology
  • Cardiovascular Devices
  • Canada
  • North America
  • Market Size

PANDOLFO HAS CONTRIBUTED TO THE CLINICAL AND GENETIC STUDY OF OTHER INHERITED ATAXIAS, OF THE GENETICS AND PHARMACOGENETICS OF EPILEPSY, OF SEVERAL RARE INHERITED NEUROLOGICAL DISEASES, AND OF THE GENETIC PREDISPOSITION TO STROKE.

  • Cardiovascular Devices
  • Pharmaceutical
  • Prosthesis
  • United States
  • Company

ONE UNIT REFERS TO ONE PAC.

  • Cardiovascular Devices
  • Health Services
  • Medical Device
  • North America
  • Market Size

One unit refers to one PAC.

  • Cardiology
  • Cardiovascular Devices
  • Catheter
  • France
  • Sanofi S.A.